HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA BSE Rule Permits Tallow With .15% Hexane-Insoluble Impurities

This article was originally published in The Rose Sheet

Executive Summary

FDA's 1interim final rule prohibiting certain bovine risk materials in cosmetics, dietary supplements and foods to minimize exposure to bovine spongiform encephalopathy will be effective immediately upon publication in the Federal Register, slated for July 14
Advertisement

Related Content

FDA Releases Final Recordkeeping Rule For Cosmetics With Bovine Material
FDA Releases Final Recordkeeping Rule For Cosmetics With Bovine Material
BSE interim final rule
BSE interim final rule
CTFA, SDA Question Tallow Supply In Response To BSE Rule
FDA Rule Seeks To Eliminate Potential For Spreading BSE In Cosmetics
FDA Rule Seeks To Eliminate Potential For Spreading BSE In Cosmetics
Advertisement
UsernamePublicRestriction

Register

RS012278

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel